Custom sarcoma treatment via organoids from patients

Researchers at UCLA developed the largest collection of sarcoma patient-derived organoids to date, helping identify the best treatments for each patient. Since sarcomas are rare and complex with over 100 types, effective treatments are hard to find. These organoids allow doctors to test many drugs quickly, showing promise for more personalized therapies.